Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition
NCT02520232, Not applicable, Completed, University Hospital, Bordeaux
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition | ClinicalTrials.gov |
| NCT number | NCT02520232 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 139 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University Hospital, Bordeaux | ClinicalTrials.gov |
| Conditions | Alzheimer's Disease | ClinicalTrials.gov |
| Interventions | Combination of aerobic and strength exercises, Stretching and balance exercise program | ClinicalTrials.gov |
| First posted | 2015-08-11 | ClinicalTrials.gov |
| Last updated | 2026-06-01 | ClinicalTrials.gov |
Registered outcomes 20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Executive functions (Mean z score) | 0 to 3 months after inclusion visit | Mean z score of performances in five tasks involving executive functions (Trail Making Test, Random Number Generation Task, Stroop Color Word Test, Eriksen's Flanker Task, Letter Running Span Task). | ClinicalTrials.gov |
| Primary | Executive functions (Mean z score) | 6 to 9 months after inclusion visit | ClinicalTrials.gov | |
| Primary | Executive functions (Mean z score) | 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Senior Fitness Test score | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Body Mass Index | Day 0 (Inclusion visit) | ClinicalTrials.gov | |
| Secondary | Energy expenditure related to physical activity (Actimetry) | 3 to 6 months after inclusion visit | Actimetry meseare | ClinicalTrials.gov |
| Secondary | Heart rate variability at rest | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Blood pressure | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Depression score | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Self-efficacy score | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Quality of life score | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Stage of change score related to physical activity | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Score at Verbal working-memory span | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Reaction time in a two-choice reaction time task | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Error rate in a two-choice reaction time task | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Logic memory score | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit ; 12 to 15 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Grey and white matter volumes in regions of interest | 0 to 3 months after inclusion visit ; 6 to 9 months after inclusion visit | ClinicalTrials.gov | |
| Secondary | Cerebral perfusion in the same regions of interest | 0 to 3 months after inclusion visit ; 0 to 15 days after inclusion visit ; 6 to 9 months after inclusion visit | Brain Imaging | ClinicalTrials.gov |
| Secondary | Resting State Networks Activity | 0 to 3 months after inclusion visit ; 0 to 15 days after inclusion visit ; 6 to 9 months after inclusion visit | Brain Imaging | ClinicalTrials.gov |
| Secondary | Brain glucose metabolism | 0 to 3 months after inclusion visit ; 0 to 15 days after inclusion visit ; 6 to 9 months after inclusion visit | Brain Imaging | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 7
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Eriksen Flanker Task | Primary outcome | ConductCognition |
| Random Number Generation | Primary outcome | ConductCognition |
| Running Span | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
| Choice Reaction Time | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)